{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:47:26Z","timestamp":1782197246456,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Scientific Technology Plan Program for Healthcare in Zhejiang Province","award":["2023RC098"],"award-info":[{"award-number":["2023RC098"]}]},{"name":"National Oncology Clinical Key Speciality","award":["2023-GJZK-001"],"award-info":[{"award-number":["2023-GJZK-001"]}]},{"name":"Key Construction Disciplines of Provincial and Municipal Co construction of Zhejiang","award":["2023-SSGJ-002"],"award-info":[{"award-number":["2023-SSGJ-002"]}]},{"name":"Zhejiang Province Postdoctoral Research Project","award":["ZJ2024156"],"award-info":[{"award-number":["ZJ2024156"]}]},{"name":"Science and technology project of Jiaxing","award":["2025CGZ041"],"award-info":[{"award-number":["2025CGZ041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10863-026-10091-4","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:13:36Z","timestamp":1776237216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA hypermethylation drives BVES-mediated autophagy to promote cisplatin resistance in lung adenocarcinoma"],"prefix":"10.1007","volume":"58","author":[{"given":"Xiaoli","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"10091_CR1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171039","volume":"37","author":"JN Amunjela","year":"2017","unstructured":"Amunjela JN, Tucker SJ (2017) Dysregulation of POPDC1 promotes breast cancer cell migration and proliferation. Biosci Rep 37:BSR20171039","journal-title":"Biosci Rep"},{"key":"10091_CR2","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1124\/jpet.116.233908","volume":"358","author":"RA Barnard","year":"2016","unstructured":"Barnard RA, Regan DP, Hansen RJ, Maycotte P, Thorburn A, Gustafson DL (2016) Autophagy inhibition delays early but not late-stage metastatic disease. J Pharmacol Exp Ther 358:282\u2013293","journal-title":"J Pharmacol Exp Ther"},{"key":"10091_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"10091_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1200\/JCO.21.01589","volume":"40","author":"JE Chaft","year":"2022","unstructured":"Chaft JE, Shyr Y, Sepesi B, Forde PM (2022) Preoperative and postoperative systemic therapy for operable non-small-cell lung cancer. J Clin Oncol 40:546\u2013555","journal-title":"J Clin Oncol"},{"key":"10091_CR5","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","volume":"21","author":"JK Christman","year":"2002","unstructured":"Christman JK (2002) 5-azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21:5483\u20135495","journal-title":"Oncogene"},{"key":"10091_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1021\/acsmedchemlett.8b00474","volume":"10","author":"GNL Chua","year":"2019","unstructured":"Chua GNL, Wassarman KL, Sun H, Alp JA, Jarczyk EI, Kuzio NJ et al (2019) Cytosine-based TET enzyme inhibitors. ACS Med Chem Lett 10:180\u2013185","journal-title":"ACS Med Chem Lett"},{"key":"10091_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/15592294.2014.995542","volume":"10","author":"C Desjobert","year":"2015","unstructured":"Desjobert C, El Ma\u00ef M, G\u00e9rard-Hirne T, Guianvarc\u2019h D, Carrier A, Pottier C et al (2015) Combined analysis of DNA methylation and cell cycle in cancer cells. Epigenetics 10:82\u201391","journal-title":"Epigenetics"},{"key":"10091_CR8","doi-asserted-by":"publisher","first-page":"2929381","DOI":"10.1155\/2017\/2929381","volume":"2017","author":"X Dong","year":"2017","unstructured":"Dong X, Hou Q, Chen Y, Wang X (2017) Diagnostic value of the methylation of multiple gene promoters in serum in hepatitis B virus-related hepatocellular carcinoma. Dis Markers 2017:2929381","journal-title":"Dis Markers"},{"key":"10091_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04403-0","volume":"21","author":"W Duan","year":"2023","unstructured":"Duan W, Liu W, Xia S, Zhou Y, Tang M, Xu M et al (2023) Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. J Transl Med 21:547","journal-title":"J Transl Med"},{"key":"10091_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/1055-9965.EPI-07-2518","volume":"17","author":"Q Feng","year":"2008","unstructured":"Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM et al (2008) DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 17:645\u2013654","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10091_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00807-y","volume":"14","author":"LY Feng","year":"2021","unstructured":"Feng LY, Huang YZ, Zhang W, Li L (2021) LAMA3 DNA methylation and transcriptome changes associated with chemotherapy resistance in ovarian cancer. J Ovarian Res 14:67","journal-title":"J Ovarian Res"},{"key":"10091_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.01.003","volume":"44","author":"DA Fennell","year":"2016","unstructured":"Fennell DA, Summers Y, Cadranel J, Benepal T, Christoph DC, Lal R et al (2016) Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer. Cancer Treat Rev 44:42\u201350","journal-title":"Cancer Treat Rev"},{"key":"10091_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01391-4","volume":"15","author":"K Fu","year":"2022","unstructured":"Fu K, Xie F, Wang F, Fu L (2022) Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance. J Hematol Oncol 15:173","journal-title":"J Hematol Oncol"},{"key":"10091_CR14","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2147\/OTT.S192364","volume":"12","author":"P Han","year":"2019","unstructured":"Han P, Lei Y, Li D, Liu J, Yan W, Tian D (2019) Ten years of research on the role of BVES\/ POPDC1 in human disease: a review. Onco Targets Ther 12:1279\u20131291","journal-title":"Onco Targets Ther"},{"key":"10091_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00962-9","volume":"20","author":"P Han","year":"2022","unstructured":"Han P, Lei Y, Liu J, Liu J, Huang H, Tian D et al (2022) Cell adhesion molecule BVES functions as a suppressor of tumor cells extrusion in hepatocellular carcinoma metastasis. Cell Commun Signal 20:149","journal-title":"Cell Commun Signal"},{"key":"10091_CR16","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/carcin\/bgq144","volume":"31","author":"M Kim","year":"2010","unstructured":"Kim M, Jang HR, Haam K, Kang TW, Kim JH, Kim SY et al (2010) Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer. Carcinogenesis 31:1685\u20131693","journal-title":"Carcinogenesis"},{"key":"10091_CR17","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1126\/science.1143777","volume":"317","author":"D Kioussis","year":"2007","unstructured":"Kioussis D, Georgopoulos K (2007) Epigenetic flexibility underlying lineage choices in the adaptive immune system. Science 317:620\u2013622","journal-title":"Science"},{"key":"10091_CR18","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108863","volume":"40","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky DJ, Petroni G, Amaravadi RK, Baehrecke EH, Ballabio A, Boya P et al (2021) Autophagy in major human diseases. EMBO J 40:e108863","journal-title":"EMBO J"},{"key":"10091_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","volume":"70","author":"M Kulis","year":"2010","unstructured":"Kulis M, Esteller M (2010) DNA methylation and cancer. Adv Genet 70:27\u201356","journal-title":"Adv Genet"},{"key":"10091_CR20","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.7150\/thno.45631","volume":"10","author":"X Le","year":"2020","unstructured":"Le X, Mu J, Peng W, Tang J, Xiang Q, Tian S et al (2020) DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative\/ER stress-mediated apoptosis and pyroptosis. Theranostics 10:9495\u20139511","journal-title":"Theranostics"},{"key":"10091_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, He S, Ma B (2020) Autophagy and autophagy-related proteins in cancer. Mol Cancer 19:12","journal-title":"Mol Cancer"},{"key":"10091_CR22","doi-asserted-by":"publisher","first-page":"11798","DOI":"10.1021\/acs.jmedchem.1c00579","volume":"64","author":"Y Li","year":"2021","unstructured":"Li Y, Yang G, Yang C, Tang P, Chen J, Zhang J et al (2021) Targeting autophagy-related epigenetic regulators for cancer drug discovery. J Med Chem 64:11798\u201311815","journal-title":"J Med Chem"},{"key":"10091_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166583","volume":"1869","author":"Y Li","year":"2023","unstructured":"Li Y, Fan Z, Meng Y, Liu S, Zhan H (2023) Blood-based DNA methylation signatures in cancer: a systematic review. Biochimica Et Biophysica Acta (BBA) 1869:166583","journal-title":"Biochimica Et Biophysica Acta (BBA)"},{"key":"10091_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101057","volume":"73","author":"J Liang","year":"2024","unstructured":"Liang J, Bi G, Huang Y, Zhao G, Sui Q, Zhang H et al (2024) MAFF confers vulnerability to cisplatin-based and ionizing radiation treatments by modulating ferroptosis and cell cycle progression in lung adenocarcinoma. Drug Resist Updat 73:101057","journal-title":"Drug Resist Updat"},{"key":"10091_CR25","doi-asserted-by":"publisher","first-page":"e103181","DOI":"10.15252\/embj.2019103181","volume":"39","author":"Z Lin","year":"2020","unstructured":"Lin Z, Niu Y, Wan A, Chen D, Liang H, Chen X et al (2020) RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J 39:e103181","journal-title":"EMBO J"},{"key":"10091_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-3-030-22254-3_14","volume":"1164","author":"N Mahmood","year":"2019","unstructured":"Mahmood N, Rabbani SA (2019) Targeting DNA hypomethylation in malignancy by epigenetic therapies. Adv Exp Med Biol 1164:179\u2013196","journal-title":"Adv Exp Med Biol"},{"key":"10091_CR27","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1158\/1078-0432.CCR-22-3699","volume":"29","author":"LN Mathieu","year":"2023","unstructured":"Mathieu LN, Larkins E, Sinha AK, Mishra-Kalyani PS, Jafri S, Kalavar S et al (2023) FDA approval summary: atezolizumab as adjuvant treatment following surgical resection and platinum-based chemotherapy for stage II to IIIA NSCLC. Clin Cancer Res 29:2973\u20132978","journal-title":"Clin Cancer Res"},{"key":"10091_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0161-3","volume":"6","author":"T Nishimura","year":"2020","unstructured":"Nishimura T, Tooze SA (2020) Emerging roles of ATG proteins and membrane lipids in autophagosome formation. Cell Discovery 6:32","journal-title":"Cell Discovery"},{"key":"10091_CR29","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/cells9081850","volume":"9","author":"SP Nunes","year":"2020","unstructured":"Nunes SP, Henrique R, Jer\u00f3nimo C, Paramio JM (2020) DNA methylation as a therapeutic target for bladder cancer. Cells 9:1850","journal-title":"Cells"},{"key":"10091_CR30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/gutjnl-2015-310255","volume":"66","author":"B Parang","year":"2017","unstructured":"Parang B, Kaz AM, Barrett CW, Short SP, Ning W, Keating CE et al (2017) BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis. Gut 66:852\u2013862","journal-title":"Gut"},{"key":"10091_CR31","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1111\/nph.18212","volume":"235","author":"A P\u0159ibylov\u00e1","year":"2022","unstructured":"P\u0159ibylov\u00e1 A, Fischer L, Pyott DE, Bassett A, Molnar A (2022) DNA methylation can alter CRISPR\/Cas9 editing frequency and DNA repair outcome in a target-specific manner. New Phytol 235:2285\u20132299","journal-title":"New Phytol"},{"key":"10091_CR32","doi-asserted-by":"publisher","first-page":"4401","DOI":"10.1080\/15548627.2021.1917132","volume":"17","author":"J Qi","year":"2021","unstructured":"Qi J, Xing Y, Liu Y, Wang MM, Wei X, Sui Z et al (2021) MCOLN1\/TRPML1 finely controls oncogenic autophagy in cancer by mediating zinc influx. Autophagy 17:4401\u20134422","journal-title":"Autophagy"},{"key":"10091_CR33","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1038\/onc.2016.180","volume":"35","author":"H Rajabi","year":"2016","unstructured":"Rajabi H, Tagde A, Alam M, Bouillez A, Pitroda S, Suzuki Y et al (2016) DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells. Oncogene 35:6439\u20136445","journal-title":"Oncogene"},{"key":"10091_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/950140","volume":"2011","author":"A Salskov","year":"2011","unstructured":"Salskov A, Hawes SE, Stern JE, Feng Q, Jordan CD, Wiens L et al (2011) Hypermethylation of CCND2 may reflect a smoking-induced precancerous change in the lung. J Oncol 2011:950140","journal-title":"J Oncol"},{"key":"10091_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37542-5","volume":"14","author":"Y Shi","year":"2023","unstructured":"Shi Y, Niu Y, Yuan Y, Li K, Zhong C, Qiu Z et al (2023) PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer. Nat Commun 14:1932","journal-title":"Nat Commun"},{"key":"10091_CR36","first-page":"4121","volume":"34","author":"A Shirahata","year":"2014","unstructured":"Shirahata A, Hibi K (2014) Serum vimentin methylation as a potential marker for colorectal cancer. Anticancer Res 34:4121\u20134125","journal-title":"Anticancer Res"},{"key":"10091_CR37","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333","journal-title":"CA Cancer J Clin"},{"key":"10091_CR38","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1016\/j.clbc.2020.05.009","volume":"20","author":"I Stastny","year":"2020","unstructured":"Stastny I, Zubor P, Kajo K, Kubatka P, Golubnitschaja O, Dankova Z (2020) Aberrantly methylated cfDNA in body fluids as a promising diagnostic tool for early detection of breast cancer. Clin Breast Cancer 20:e711\u2013e722","journal-title":"Clin Breast Cancer"},{"key":"10091_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ijc.23607","volume":"123","author":"C Stresemann","year":"2008","unstructured":"Stresemann C, Lyko F (2008) Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer 123:8\u201313","journal-title":"Int J Cancer"},{"key":"10091_CR40","first-page":"52","volume":"26","author":"J Sun","year":"2023","unstructured":"Sun J, Chen J (2023) Research progress of DNA methylation in Cisplatin resistance in lung cancer. Zhongguo Fei Ai Za Zhi 26:52\u201358","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10091_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0417-4","volume":"9","author":"Y Wang","year":"2017","unstructured":"Wang Y, He T, Herman JG, Linghu E, Yang Y, Fuks F et al (2017) Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth. Clin Epigenetics 9:115","journal-title":"Clin Epigenetics"},{"key":"10091_CR42","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1080\/10717544.2022.2120566","volume":"29","author":"N Wathoni","year":"2022","unstructured":"Wathoni N, Puluhulawa LE, Joni IM, Muchtaridi M, Mohammed AFA, Elamin KM et al (2022) Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer. Drug Deliv 29:2959\u20132970","journal-title":"Drug Deliv"},{"key":"10091_CR43","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1172\/JCI44228","volume":"121","author":"CS Williams","year":"2011","unstructured":"Williams CS, Zhang B, Smith JJ, Jayagopal A, Barrett CW, Pino C et al (2011) BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. J Clin Invest 121:4056\u20134069","journal-title":"J Clin Invest"},{"key":"10091_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25032-5","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Xu G, Wang B, Liu Y, Zhang L, Jing T et al (2021) USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade. Nat Commun 12:4852","journal-title":"Nat Commun"},{"key":"10091_CR45","doi-asserted-by":"publisher","first-page":"e220426","DOI":"10.1001\/jamanetworkopen.2022.0426","volume":"5","author":"J Yu","year":"2022","unstructured":"Yu J, Gao Y, Chen L, Wu D, Shen Q, Zhao Z et al (2022) Effect of S-1 plus oxaliplatin compared with fluorouracil, leucovorin plus oxaliplatin as perioperative chemotherapy for locally advanced, resectable gastric cancer: a randomized clinical trial. JAMA Netw Open 5:e220426","journal-title":"JAMA Netw Open"},{"key":"10091_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang H, Deng T, Liu R, Ning T, Yang H, Liu D et al (2020) CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer 19:43","journal-title":"Mol Cancer"},{"key":"10091_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.5047","volume":"48","author":"L Zhu","year":"2021","unstructured":"Zhu L, Wang Y, Lv W, Wu X, Sheng H, He C et al (2021) Schizandrin a can inhibit non-small cell lung cancer cell proliferation by inducing cell cycle arrest, apoptosis and autophagy. Int J Mol Med 48:1\u201313","journal-title":"Int J Mol Med"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-026-10091-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-026-10091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:04:58Z","timestamp":1782194698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-026-10091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10091"],"URL":"https:\/\/doi.org\/10.1007\/s10863-026-10091-4","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collection of clinical samples and related experiments were conducted per the ethical requirements of the Medical Ethics Committee of the Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing) (NO.2025-LP-312). Animal experiments were performed under a project license (NO. JXYY2025-027) granted by the ethics committee of the Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), in compliance with institutional guidelines for the care and use of animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}